Optimized Medicine is the pursuit of your best possible biology — through rigorous evidence, systems thinking, and a clinical team designed to make improvement sustainable.
The Problem True Health Exists to Solve
A patient arrived recently with a folder with multiple test results from multiple clinics and no other available medical records, such as physician notes. She has been experiencing chronic fatigue and brain fog that started after a Covid-19 infection. She was concerned about a hormonal imbalance and had been told she has “adrenal fatigue” but NOT confirmed hypoadrenalism. She had purchased a costly cocktail of “adrenal support” supplements.
Her question was simple.
“Why do I still feel this fatigue and brain fog?”
She had not been ignored by the medical system. She had been processed by it.
Everything had been measured. Almost nothing had been understood.
That folder is a map of modern medicine’s integrity deficit — not because clinicians lack intelligence or commitment, but because the structures surrounding patient care increasingly prevent careful reasoning about complex biology.
The Structural Problem
Patients navigating chronic cardiometabolic disease today typically encounter one of three medical ecosystems: the health system, the wellness and functional medicine industry, and the longevity influencer ecosystem.
Each emerged partly in response to the shortcomings of the others. Each contains clinicians acting with genuine integrity. But each also contains structural incentives that often undermine careful clinical reasoning.
The goal here is not to dismiss these models wholesale. It is to examine where they fail — and why a different clinical operating system may be necessary for complex chronic disease.
🏥 Model One: The Health System
This critique is not directed at individual physicians. Many clinicians within large institutions deliver exceptional care under difficult constraints.
The problem is structural.
Large healthcare organizations operate within reimbursement models that reward procedural volume, brief encounters, and departmental revenue streams. These incentives make careful longitudinal reasoning about complex chronic disease difficult to sustain.
When clinicians are responsible for large patient panels within short visits, even excellent physicians find themselves treating individual problems rather than integrating the biological system as a whole.
A patient with metabolic syndrome, insulin resistance, early cardiovascular disease, and sleep-disordered breathing will often be referred to endocrinology, cardiology, pulmonology, and perhaps a dietitian — none of whom communicate meaningfully with each other.
Each specialist treats their organ. Nobody treats the patient.
Access compounds the problem. Meaningful appointments frequently require weeks to months, culminating in encounters that cannot accommodate the complexity of chronic disease.
The result is not negligence. It is fragmentation — systemic, structural, and largely invisible to the patients who experience it.
🌿 Model Two: Wellness and Functional Medicine
The functional medicine movement emerged partly as a legitimate response to the limitations of conventional care. It asks questions conventional medicine sometimes neglects: What is driving this condition? What changed in this patient’s biology? What does the full biological picture look like?
These are important questions. Many practitioners who ask them are genuinely motivated by patient wellbeing, and some practice with real rigor and intellectual integrity.
But the core issue is epistemological.
A practitioner can be entirely well-intentioned and still cause harm when interventions are not grounded in validated clinical evidence. Good intentions do not validate a test or justify an intervention. The same evidence standard that applies to pharmaceuticals must apply to functional protocols, specialty panels, and botanical therapies.
Patterns that warrant scrutiny include:
Laboratory panels without established clinical utility, ordered because they generate intervention indications rather than because they change management
Supplement protocols lacking controlled clinical trial evidence, particularly when sold by the same practitioner who prescribes them
Simplified “root cause” narratives applied to complex multisystem disease — single villains for conditions that require systems thinking
Diagnostic labels absent from peer-reviewed literature applied to genuine symptoms that deserve rigorous investigation
Business models dependent on ongoing patient dependency rather than resolution
Some clinicians within functional medicine operate with genuine rigor: validated testing, acknowledged uncertainty, transparent financial relationships, a willingness to refer to conventional specialists. That practitioner is practicing with integrity regardless of the label on their door.
The criticism here is of the commercial ecosystem — not every practitioner within it.
📈 Model Three: The Longevity Influencer Ecosystem
A third model has emerged in the past decade: physician-influencers promoting longevity optimization to large audiences.
Some contributions have been genuinely valuable — particularly the emphasis on metabolic health, earlier cardiovascular risk assessment, and exercise as medicine. These ideas have real clinical merit and have moved mainstream medicine in useful directions.
However, the ecosystem carries its own structural weaknesses.
Several prominent figures have promoted therapies with minimal human evidence — for example, rapamycin use in healthy adults, where most data derive from animal models or disease states, and the risk-benefit profile in healthy humans remains uncertain in peer-reviewed clinical trials. Others have recommended products tied to undisclosed financial relationships or presented speculative extrapolation as established science.
The intellectual framework has merit. The credibility of some of its most visible advocates does not always match it. Patients who built health protocols around these voices deserve better than discovering that the physician-influencer model has its own integrity deficit.
⚖️ The Landscape in Full
✅ Medicine with Integrity
The real distinction is not between conventional and functional medicine. It is between medicine practiced with intellectual honesty and medicine practiced for other ends.
🧠 The Clinical Framework: Systems Biology
Three principles guide the clinical approach.
The body is a complex biological system — not a collection of organs, and not a machine awaiting the correct protocol.
Clinical decisions follow probability and evidence, not narrative convenience.
Sustained health improvement requires patient agency supported by coordinated team infrastructure.
Systems Thinking Over Organ Thinking
Chronic cardiometabolic disease rarely arises from a single cause. Insulin resistance may reflect interacting drivers: visceral adiposity, sleep disruption, chronic stress physiology, sedentary behavior, altered gut biome, and genetic susceptibility. In most patients, several coexist.
The clinical task is not to identify a single villain. It is to determine which drivers matter most for this patient at this moment — and which are modifiable given their biology, circumstances, and resources. That is harder than promising a root cause. It is more honest. And it is far more likely to produce durable results.
Root Cause Analysis as a Clinical Discipline
Understanding accumulates through time, continuity, and repeated observation. Clinical reasoning becomes an iterative process: construct a hypothesis from history and selective testing → implement a targeted intervention → observe the biological response → update the model.
Upstream Mapping — History focuses on physiological turning points: when did function change, and what shifted around it? This reconstructs a biological timeline rather than a diagnostic list.
Hypothesis-Driven Testing — Tests answer specific questions: Does this result alter management? Does it improve risk prediction? If not, it adds noise. More data does not automatically produce more insight.
Circuit-Level Assessment — Metabolic, endocrine, cardiovascular, and inflammatory systems are mapped as an interacting whole, not evaluated in isolation by specialists who never communicate.
Iterative Modeling — The model is continuously updated as interventions produce — or fail to produce — expected responses.
Individual Biology, Not Population Averages
Guidelines describe population averages. Patients are not averages.
Biological variation in drug metabolism, cardiovascular risk, insulin sensitivity, inflammatory response, and body composition frequently changes clinical decisions: pharmacogenomic analysis before initiating medications with known metabolizer variation; DXA body composition rather than BMI as a proxy for metabolic risk; continuous glucose monitoring to characterize metabolic phenotype before prescribing; advanced lipoprotein analysis when standard panels are insufficient for risk stratification.
🏃 Lifestyle as Primary Biology
Lifestyle medicine is not adjunctive. It is primary biology — the foundation upon which everything else operates. Diagnostics and medications operate on top of that foundation, not instead of it.
Cardiorespiratory fitness is among the strongest independent predictors of all-cause mortality across multiple longitudinal cohorts.¹
The Implementation Constraint
Even when a diagnosis is correct and treatment recommendations are sound, outcomes frequently fail to improve.
The limiting factor is often not knowledge. It is execution.
Large trials — including the Diabetes Prevention Program and Look AHEAD — demonstrate that intensive lifestyle intervention significantly improves cardiometabolic outcomes.²⁻³ Yet sustaining behavioral change outside structured support remains the central challenge of chronic disease care.
Chronic disease management depends on behaviors repeated daily over years: sleep timing, physical activity, nutrition, medication adherence, and stress regulation. These behaviors are shaped by more than motivation — they are influenced by work schedules, family obligations, economic constraints, psychological health, and environmental conditions.
Clinical reasoning alone does not change physiology. Human behavior does.
This is why clinical infrastructure matters. The physician identifies the biological drivers. The team translates recommendations into daily action.
Even with strong support, not every patient succeeds. Biology interacts with circumstance. Honest medicine acknowledges this limitation while building the strongest possible environment for success.
👥 The Team: Clinical Infrastructure, Not Support Staff
Systems-based care cannot rely on a single clinician. Multidisciplinary team-based care has repeatedly demonstrated improved glycemic control, cardiovascular risk factor reduction, and adherence compared with physician-only models.⁴⁻⁵
True Health operates as an integrated clinical team in which each member functions at the top of their training within a shared philosophy of care.
This structure is not an amenity. It is a clinical infrastructure.
Without it, many recommendations remain theoretical.
The physician synthesizes. The team implements. The therapeutic relationship sustains it. A clinical recommendation is only as effective as the patient’s capacity to act on it — and the team’s capacity to support that action over time.
Specialty Partnerships: Plug-and-Play Integration
Some clinical domains require dedicated specialty expertise that cannot be fully housed within a single practice. The model here is deliberate plug-and-play integration — pre-built working relationships with concierge-level specialty practices that provide superior access and genuine clinical coordination, not referral into the health system queue.
This is not a referral network. It is a curated ecosystem of aligned specialty partners — each selected for clinical quality, access, and philosophical compatibility with an integrated, patient-centered model of care.
🛌 Sleep Medicine — Sleep-disordered breathing, circadian dysfunction, and chronic insomnia are among the most modifiable upstream drivers of insulin resistance, cardiovascular risk, and metabolic dysfunction — yet they are systematically underdiagnosed and undertreated in standard cardiometabolic care. This practice maintains a working relationship with a dedicated sleep medicine specialty practice, providing patients with access that bypasses the weeks-to-months wait typical of health system referrals.
For chronic insomnia specifically, Cognitive Behavioral Therapy for Insomnia (CBTi) is the evidence-based first-line treatment with stronger long-term outcomes than pharmacotherapy and no dependency risk.⁶ This practice uses DrLullaby (drlullaby.com) as its digital CBTi delivery layer: a clinician-delivered platform backed by the University of Chicago, combining live video visits with secure messaging and wearable integration (including Oura) for data-informed insomnia treatment. This is not a self-help app — it is structured clinical care.
🧠 Brain Health — Cognitive function, neurological resilience, and the intersection of metabolic disease with brain health are increasingly recognized as core components of healthspan — not separate concerns. A working relationship with a concierge-level brain health specialty practice extends the cardiometabolic framework into cognitive longevity: early identification of risk, metabolic contributors to cognitive decline, and integrated management across the metabolic-neurological axis.
🧬 Clinical Genetics — Genetic architecture shapes cardiovascular risk, drug metabolism, nutrient utilization, and disease susceptibility in ways that population-average guidelines cannot capture. A relationship with a dedicated clinical genetics practice allows genomic data to be integrated meaningfully into clinical decision-making — not as a consumer wellness product, but as a tool for genuine risk stratification and personalized treatment planning.
🤝 The Therapeutic Relationship
Technology, testing, tracking metrics and outcomes, and team structure are necessary. They are not sufficient.
The therapeutic relationship — the quality of trust, communication, and genuine investment between clinician and patient — is itself a determinant of clinical outcomes. It shapes whether patients share what matters, whether they act on recommendations, and whether they return when things aren’t working. In this practice, that means the physician knows the patient’s biology, history, and life context — not just their problem list. Recommendations come with reasoning. Uncertainty is named rather than papered over. The patient is treated as an intelligent adult capable of understanding their own biology.
This is not a soft consideration adjacent to real medicine. It is the connective tissue that holds the operating system together.
📊 Measuring What Matters
Clinical philosophy is meaningless without outcomes.
Relevant measures in this practice include: glycemic control and insulin sensitivity improvement; visceral adiposity reduction — measured directly by DXA, not estimated; cardiometabolic risk marker trajectories across lipoproteins, inflammatory markers, and blood pressure; functional capacity as longevity predictors; appropriate medication reduction where biological improvement warrants it; and sustained behavioral adherence over months and years, not weeks.
Longitudinal tracking of these metrics allows clinical reasoning to be tested rather than merely asserted. The model is accountable to the data it produces.
🔧 The Operational Difference: Three Layers of Optimization
The knowledge required to treat cardiometabolic disease already exists in preventive cardiology, endocrinology, and lifestyle medicine. This practice is not built on a novel theory of disease.
The distinguishing feature is the operational environment — and it operates on three distinct, mutually reinforcing layers.
Layer One — Clinical Optimization: Systems biology, root cause analysis, lifestyle as primary biology, individualized evidence-based decision making. The what of care: reasoning carefully about complex biology and treating the whole patient rather than isolated diagnoses.
Layer Two — Operational Optimization: Access design, team architecture, specialty partnerships, care delivery mechanics, and outcome tracking. The how of care: the infrastructure that determines whether clinical knowledge actually reaches the patient consistently, repeatedly, and over the years required for biological change.
Layer Three — Meta-Optimization: Continuous innovation in how the practice itself learns and improves. Systematic outcome tracking creates a feedback loop — clinical decisions inform measurable results, results inform future decisions, and the model evolves. The practice is not a static protocol. It is a learning system designed to get better over time.
Remote Physiological Monitoring (RPM) and Chronic Care Management (CCM): Structured programs that extend clinical touch between visits, capture real-world physiological data continuously, and generate reimbursable care pathways aligned with CMS evidence standards. RPM transforms wearable and device data from passive tracking into actionable clinical intelligence — flagging trends, triggering outreach, and enabling intervention before problems escalate.
Integrated technology stack: Purpose-built to connect the care team, patient-facing tools, and physiological data streams into a single coherent clinical workflow — reducing friction, improving continuity, and making the team model operationally scalable.
Outcome data infrastructure: Longitudinal tracking of cardiometabolic biomarkers, functional capacity, behavioral adherence, and patient-reported outcomes — not as administrative documentation but as a clinical learning system that informs future decisions.
The digital layer is not a feature. It is the nervous system of the operating system.
🏛️ The Honest Case for Concierge Medicine
This practice operates within a membership model. The criticism of concierge medicine — that it reinforces a two-tiered healthcare system — is legitimate and deserves a direct answer.
Many physicians have concluded that careful, longitudinal, reasoning-intensive medicine is structurally impossible inside conventional health system incentives. Membership practices attempt to solve that problem by preserving two resources modern healthcare chronically rations: time and continuity.
The ethical question is not whether concierge medicine exists. It is how it is practiced.
Beyond individual practice, membership models may function as prototype environments — places where integrated, outcomes-focused care can be tested, refined, and eventually translated into approaches larger systems could adopt. The ethical obligation of a practice like this is not only to serve its members well. It is to demonstrate that the model works.
🤝 Who Thrives in This Model
⭐ The North Star
The human body is not a machine awaiting the correct supplement, peptide, infusion, or food restriction protocol. It is a complex biological system shaped by genetics, behavior, environment, and time — one that responds to thoughtful, coordinated, evidence-grounded care in ways no supplement line or influencer protocol can replicate.
Modern medicine already possesses much of the knowledge required to address chronic disease. What it often lacks are environments that allow careful reasoning, appropriate pharmaceutical prescribing based on best evidence, coordinated care, and sustained behavioral implementation over the years required for biological change.
Good medicine is not the performance of manufactured certainty. It is the disciplined, intellectually honest pursuit of understanding — delivered by a team that shares that commitment, sustained across the years required for it to matter.
Optimized Medicine is not a brand. It is not a doctrine.
It is a clinical operating system for practicing medicine thoughtfully, transparently, and in genuine partnership with patients over the years required for health to change.
Anthony Pick— MD, CDCES, CCD · Endocrinology & Cardiometabolic Medicine · True Health · Deerfield, Illinois
References
Blair SN et al. Physical fitness and all-cause mortality. JAMA. 1989;262(17):2395–2401.
Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM. 2002;346(6):393–403.
Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. NEJM. 2013;369(2):145–154.
Wagner EH et al. Improving chronic illness care: translating evidence into action. Health Affairs. 2001;20(6):64–78.
Tricco AC et al. Effectiveness of quality improvement strategies on the management of diabetes. BMJ. 2012;344:e1802.
Qaseem A et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133.